Open access
Oct 2026
R0 resection following neoadjuvant PD-1 inhibition with paclitaxel-cisplatin is associated with improved overall survival in locally advanced and recurrent oral squamous cell carcinoma: multicenter retrospective cohort study
In treatment-naive and recurrent LA-OSCC, neoadjuvant chemoimmunotherapy followed by response-directed R0 resection and risk-adapted radiotherapy was associated with improved OS, and retrospective associations warrant confirmation in prospective randomized trials.
Qi-Wei Wang, Yan Liu, L. Zuo et al.
· Annals medicus · 0 citations